Synaptogenix Stock Analysis

Synaptogenix Stock Analysis Notes

The company has price-to-book ratio of 0.31. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Synaptogenix recorded earning per share (EPS) of 10.27. The entity had not issued any dividends in recent years. The firm had 1:25 split on the 5th of April 2024. Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. The company was incorporated in 2012 and is headquartered in New York, New York. Synaptogenix operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people. To find out more about Synaptogenix contact MBA MD at 973 242 0005 or learn more at https://www.synaptogen.com.

Synaptogenix Investment Alerts

Synaptogenix Upcoming and Recent Events

Synaptogenix Largest EPS Surprises

View All Earnings Estimates

Synaptogenix Environmental, Social, and Governance (ESG) Scores

Synaptogenix Stock Institutional Investors

Note, although Synaptogenix's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Synaptogenix Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.07 M.

Synaptogenix Profitablity

Management Efficiency

Synaptogenix has return on total asset (ROA) of (0.1382) % which means that it has lost $0.1382 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.075) %, meaning that it created substantial loss on money invested by shareholders. Synaptogenix's management efficiency ratios could be used to measure how well Synaptogenix manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.2 in 2024. Return On Capital Employed is likely to drop to -0.33 in 2024. Non Current Assets Total is likely to rise to about 610 K in 2024, whereas Total Assets are likely to drop slightly above 28.6 M in 2024.

Technical Drivers

As of the 2nd of December, Synaptogenix has the Variance of 28.33, coefficient of variation of (2,835), and Risk Adjusted Performance of (0.02). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Synaptogenix, as well as the relationship between them.

Synaptogenix Price Movement Analysis

Synaptogenix Insider Trading Activities

Synaptogenix Outstanding Bonds

Synaptogenix Predictive Daily Indicators

Synaptogenix Corporate Filings

Synaptogenix Forecast Models

Synaptogenix's time-series forecasting models are one of many Synaptogenix's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Synaptogenix's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Synaptogenix prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Synaptogenix shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Synaptogenix. By using and applying Synaptogenix Stock analysis, traders can create a robust methodology for identifying Synaptogenix entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Synaptogenix analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Synaptogenix analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Synaptogenix stock analysis indicators help investors evaluate how Synaptogenix stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Synaptogenix shares will generate the highest return on investment. By understating and applying Synaptogenix stock analysis, traders can identify Synaptogenix position entry and exit signals to maximize returns.

When running Synaptogenix's price analysis, check to measure Synaptogenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synaptogenix is operating at the current time. Most of Synaptogenix's value examination focuses on studying past and present price action to predict the probability of Synaptogenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synaptogenix's price. Additionally, you may evaluate how the addition of Synaptogenix to your portfolios can decrease your overall portfolio volatility.